ICD-10 Coding for Mantle Cell Lymphoma(C83.1A, C83.11)
Complete ICD-10-CM coding and documentation guide for Mantle Cell Lymphoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Mantle Cell Lymphoma
C83.1Primary Range
Mantle cell lymphoma
This range includes all site-specific codes for mantle cell lymphoma, which is crucial for accurate diagnosis and treatment coding.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C83.1A | Mantle cell lymphoma, in remission | Use when the patient is in remission from mantle cell lymphoma. |
|
| C83.11 | Mantle cell lymphoma, lymph nodes of head, face, and neck | Use when MCL is confirmed in lymph nodes of head, face, or neck. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for mantle cell lymphoma
Essential facts and insights about Mantle Cell Lymphoma
Primary ICD-10-CM Codes for mantle cell lymphoma
Decision Criteria
clinical Criteria
- Remission confirmed by PET-CT and bone marrow biopsy
Applicable To
- MCL in remission
Excludes
- Active mantle cell lymphoma (C83.1x)
Clinical Validation Requirements
- PET-CT Deauville score 1-2
- Bone marrow biopsy <6 months
Code-Specific Risks
- Incorrectly coding active disease as remission
Coding Notes
- Ensure remission status is clearly documented.
C83.11 - Mantle cell lymphoma, lymph nodes of head, face, and neck
Use when MCL is confirmed in lymph nodes of head, face, or neck.
Applicable To
- MCL in head, face, neck lymph nodes
Excludes
- MCL in other sites
Clinical Validation Requirements
- Biopsy confirmation with CD5+, Cyclin D1+
Coding Notes
Ensure site-specific documentation is present.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Mantle Cell Lymphoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C83.1A.
Impact
Clinical: May lead to incorrect treatment, Regulatory: Non-compliance with coding standards, Financial: Potential denial of claims
Mitigation Strategy
Ensure clear documentation of immunophenotyping, Use specific lymphoma terminology
Impact
Reimbursement: May lead to incorrect DRG assignment, Compliance: Non-compliance with coding guidelines, Data Quality: Poor data quality and inaccurate health records
Mitigation Strategy
Use site-specific codes like C83.11 when the site is known.
Impact
Failure to use site-specific codes when documentation is available.
Mitigation Strategy
Implement regular audits and coder training on site-specific coding.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Mantle Cell Lymphoma, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Mantle Cell Lymphoma
Use these documentation templates to ensure complete and accurate documentation for Mantle Cell Lymphoma. These templates include all required elements for proper coding and billing.
Oncology Progress Note
Specialty: OncologyRequired Elements
- Diagnosis confirmation
- Treatment plan
- Response assessment
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Mantle Cell Lymphoma? Ask your questions below.